Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.
The cancer stem cell hypothesis, that a small population of tumour cells are responsible for tumorigenesis and cancer progression, is becoming widely accepted and recent evidence has suggested a prognostic and predictive role for such cells. Intra-tumour heterogeneity, the diversity of the cancer ce...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-03-01
|
| Series: | PLoS Computational Biology |
| Online Access: | http://europepmc.org/articles/PMC4368751?pdf=render |
| _version_ | 1828320043138547712 |
|---|---|
| author | Christopher R S Banerji Simone Severini Carlos Caldas Andrew E Teschendorff |
| author_facet | Christopher R S Banerji Simone Severini Carlos Caldas Andrew E Teschendorff |
| author_sort | Christopher R S Banerji |
| collection | DOAJ |
| description | The cancer stem cell hypothesis, that a small population of tumour cells are responsible for tumorigenesis and cancer progression, is becoming widely accepted and recent evidence has suggested a prognostic and predictive role for such cells. Intra-tumour heterogeneity, the diversity of the cancer cell population within the tumour of an individual patient, is related to cancer stem cells and is also considered a potential prognostic indicator in oncology. The measurement of cancer stem cell abundance and intra-tumour heterogeneity in a clinically relevant manner however, currently presents a challenge. Here we propose signalling entropy, a measure of signalling pathway promiscuity derived from a sample's genome-wide gene expression profile, as an estimate of the stemness of a tumour sample. By considering over 500 mixtures of diverse cellular expression profiles, we reveal that signalling entropy also associates with intra-tumour heterogeneity. By analysing 3668 breast cancer and 1692 lung adenocarcinoma samples, we further demonstrate that signalling entropy correlates negatively with survival, outperforming leading clinical gene expression based prognostic tools. Signalling entropy is found to be a general prognostic measure, valid in different breast cancer clinical subgroups, as well as within stage I lung adenocarcinoma. We find that its prognostic power is driven by genes involved in cancer stem cells and treatment resistance. In summary, by approximating both stemness and intra-tumour heterogeneity, signalling entropy provides a powerful prognostic measure across different epithelial cancers. |
| first_indexed | 2024-04-13T18:05:09Z |
| format | Article |
| id | doaj.art-03e7241f72eb425f802273e3d8c8dd91 |
| institution | Directory Open Access Journal |
| issn | 1553-734X 1553-7358 |
| language | English |
| last_indexed | 2024-04-13T18:05:09Z |
| publishDate | 2015-03-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Computational Biology |
| spelling | doaj.art-03e7241f72eb425f802273e3d8c8dd912022-12-22T02:36:05ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582015-03-01113e100411510.1371/journal.pcbi.1004115Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer.Christopher R S BanerjiSimone SeveriniCarlos CaldasAndrew E TeschendorffThe cancer stem cell hypothesis, that a small population of tumour cells are responsible for tumorigenesis and cancer progression, is becoming widely accepted and recent evidence has suggested a prognostic and predictive role for such cells. Intra-tumour heterogeneity, the diversity of the cancer cell population within the tumour of an individual patient, is related to cancer stem cells and is also considered a potential prognostic indicator in oncology. The measurement of cancer stem cell abundance and intra-tumour heterogeneity in a clinically relevant manner however, currently presents a challenge. Here we propose signalling entropy, a measure of signalling pathway promiscuity derived from a sample's genome-wide gene expression profile, as an estimate of the stemness of a tumour sample. By considering over 500 mixtures of diverse cellular expression profiles, we reveal that signalling entropy also associates with intra-tumour heterogeneity. By analysing 3668 breast cancer and 1692 lung adenocarcinoma samples, we further demonstrate that signalling entropy correlates negatively with survival, outperforming leading clinical gene expression based prognostic tools. Signalling entropy is found to be a general prognostic measure, valid in different breast cancer clinical subgroups, as well as within stage I lung adenocarcinoma. We find that its prognostic power is driven by genes involved in cancer stem cells and treatment resistance. In summary, by approximating both stemness and intra-tumour heterogeneity, signalling entropy provides a powerful prognostic measure across different epithelial cancers.http://europepmc.org/articles/PMC4368751?pdf=render |
| spellingShingle | Christopher R S Banerji Simone Severini Carlos Caldas Andrew E Teschendorff Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer. PLoS Computational Biology |
| title | Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer. |
| title_full | Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer. |
| title_fullStr | Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer. |
| title_full_unstemmed | Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer. |
| title_short | Intra-tumour signalling entropy determines clinical outcome in breast and lung cancer. |
| title_sort | intra tumour signalling entropy determines clinical outcome in breast and lung cancer |
| url | http://europepmc.org/articles/PMC4368751?pdf=render |
| work_keys_str_mv | AT christopherrsbanerji intratumoursignallingentropydeterminesclinicaloutcomeinbreastandlungcancer AT simoneseverini intratumoursignallingentropydeterminesclinicaloutcomeinbreastandlungcancer AT carloscaldas intratumoursignallingentropydeterminesclinicaloutcomeinbreastandlungcancer AT andreweteschendorff intratumoursignallingentropydeterminesclinicaloutcomeinbreastandlungcancer |